The Journal of Clinical Oncology (JCO) is a medical journal published 3 times a month (36 issues a year) by the American Society of Clinical Oncology (ASCO), with a 2010 impact factor of 18.970. JCO now accounts for nearly one in 10 of all oncology journal citations. This journal s focus is work that relates to the care of patients with cancer, e.g., clinical oncology. This journal publishes in varying formats. Original research reports are both a communication tool and reports for original research. Review articles can describe work that builds on previous original research, summarize the current state clinical oncology, or can be a point of critical analysis. Opinion is voiced in editorial formats, which include commentary and discuss controversies. There is also a format for perspectives from a person of public notoriety. Special articles are another form of communication besides original research reports, which promulgate guidelines, summaries of consensus, and other scholarly communications. Fundamental research is covered in the "Biology of Neoplasia" section.
Individuals being treated for active cancer are at particularly high risk of severe disease and death from SARS-CoV-2 infection due to aberrant immune responses from the cancer itself and from some therapies.
Nov 10, 2021
0
127
The PrE0505 phase 2 clinical trial results are published in the November 8 issue of Nature Medicine. The study evaluated the addition of durvalumab immunotherapy to standard chemotherapy in patients with previously untreated, ...
Nov 08, 2021
0
1
In the United States, Black women are more likely to have breast cancer at earlier ages and with a worse prognosis than white women. Despite this, there is a critical gap in breast cancer risk prediction models for Black ...
Oct 29, 2021
0
2
Researchers at Washington University School of Medicine in St. Louis have surveyed cancer doctors to identify differences in physician attitudes and beliefs that may contribute to a gap in referrals to genetic counseling ...
Oct 18, 2021
0
5
The lack of a breast cancer risk prediction model tailored to Black women represents a critical gap, given that U.S. Black women, on average, are more likely to have breast cancer at earlier ages and with a worse prognosis ...
Oct 08, 2021
0
71
Despite smoking's well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked. While scientists are still working to understand what spurs cancer in so-called "never-smokers," ...
Sep 30, 2021
0
75
A long-term follow up analysis of the NRG-RTOG 9804 randomized trial has shown that breast radiation following lumpectomy significantly reduces incidence of ipsilateral breast recurrence (IBR) for "low risk" DCIS. NRG-RTOG ...
Sep 27, 2021
0
3
Over the past 40 years, people in the U.S. diagnosed with cancer gained 14 million years of additional life thanks to the results of cancer clinical trials conducted by the National Cancer Institute's (NCI's) publicly funded ...
Sep 20, 2021
0
13
A new drug has shown promise in slowing the regrowth of tumors among some bowel cancer patients, according to new findings of a major trial run by researchers at UCL in collaboration with the Universities of Glasgow, Oxford, ...
Sep 20, 2021
0
46
The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means it can be difficult for patients, the lay public as well as for doctors not specialized in oncology to keep up with the evolution ...
Sep 17, 2021
1
7
